 Twist Bioscience had an abysmal 2021 year in the market, but their DNA synthesizing technology has them poised for a major rebound. The post-Covid biotech market is positioned for an overall increase in 2022, which helps offset the companys back-to-back years of posting losses on the balance sheet. 